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The patient was a 64-year-old man with chronic atrial ﬁbrillation with bradycardia. Left
ventricular ejection fraction was 34%. He was treated with biventricular pacing. Heart failure
improved from NYHA class III to II. Sympathetic nerve activity (SNA) was recorded during 6
minutes of biventricular (BV), right ventricular apical (RVA) and left ventricular (LV)
pacing. SNA was signiﬁcantly lower during biventricular pacing (49:5 4:0/min) compared
with RVA (58:8 6:9/min, p ¼ 0:016) and LV (63:3 4:3/min, p ¼ 0:002) pacing. BV
pacing improves hemodynamics and decreases SNA compared with RVA or LV pacing.
(J Arrhythmia 2006; 22: 48–51)
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Introduction
Biventricular pacing therapy is eﬀective in pa-
tients with severe congestive heart failure. It im-
proves the hemodynamic status acutely,1–3) and
improves heart failure symptoms, exercise capacity,
quality of life, and mortality and morbidity.4–7) There
have been few studies on autonomic changes during
diﬀerent pacing modes.8) We attempted to examine
the eﬀect of biventricular pacing therapy on sym-
pathetic nerve activity using the microneuro-
gram.9,10)
Case Report
The patient was a 64-year-old man with apical
type hypertrophic cardiomyopathy. He had had
paroxysmal atrial ﬁbrillation from age 55, and a
VVI permanent pacemaker was implanted at age 59
to control chronic atrial ﬁbrillation with bradycardia.
Left ventricular ejection fraction was 34%, and he
had had repeated admissions for congestive heart
failure during the past two years because his hyper-
trophic cardiomyopathy had entered the dilated
phase. He was referred to our hospital for implanta-
tion of a biventricular pacemaker. A coronary sinus
lead was added via the lateral vein, and an SSIR
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Case Report
pacemaker was implanted. The pacing mode was set
at VVI mode 80/min and VVT mode 60/min.
Pharmacological management included 0.25mg di-
goxin, 2mg temocapril, 25mg spironolactone and
20mg furosemide per day.
QRS width was 172 and 200ms for intrinsic beats,
184ms during right ventricular apical (RVA) pacing,
233ms during left ventricular (LV) pacing and
144ms during biventricular pacing (BV) (Figure 1).
After implantation of the biventricular pacemaker,
cardio-thoracic ratio decreased from 77.8% to 67.4%
(Figure 1). Heart failure improved from New York
Heart Association class III to II. Microneurogram
study was performed 30 days after the initiation of
biventricular therapy. After acceptable recordings of
sympathetic nerve activity were obtained, the fol-
lowing protocol was performed. Non-invasive BP,
respiration rate, and sympathetic neural responses to
6 minutes of pacing were recorded during BV
pacing, RVA pacing, LV pacing, and re-BV pacing.
Re-BV pacing was done to conﬁrm reproducibility
of sympathetic neural responses. Eﬀerent, postgan-
glionic muscle SNA was recorded from the right
peroneal nerve. A sterile microelectrode was inserted
into a fascicle of the peroneal nerve near the ﬁbular
head. The nerve signals were ampliﬁed (DPA-21E
and DPA-100D; Dia Medical, Tokyo, Japan), ﬁltered
(FV-664; NF Electronic Instruments, Tokyo, Japan)
at 700 to 3000Hz, rectiﬁed, and discriminated. Raw
nerve signals were integrated (time constant 0.05 s)
to produce a mean voltage display for quantitative
analysis (No. 1333; NEC San-ei, Tokyo, Japan).
Muscle sympathetic neural bursts at baseline (during
BV pacing) were readily recognized by their tight
Figure 1
Upper: Chest XP before (left panel) and
after (right panel) biventricular pacing.
After implantation of a biventricular
pacemaker, cardio-thoracic ratio de-
creased from 77.8% to 67.4%.
Lower: Conventional lead electrocar-
diogram during pacing at each site.
QRS width during BV pacing was the
shortest of each pacing site, and QRS
width during LV pacing was the longest
of each pacing site. BV, biventricular;
RV, right ventricular; LV, left ventric-
ular.
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temporal relationship to the cardiac cycle, their
increasing frequency during Valsalva maneuvers,
and their failure to respond to arousal stimuli and
stroking of the skin. SNA was quantiﬁed as the total
activity derived from the mean number of the SNA
bursts for a minute derived from four minutes of
recording. On the same day as recording SNA,
standard echocardiography including Doppler stud-
ies was performed during BV pacing, RVA pacing
and LV pacing. LV dimensions and ejection fraction
were measured by two-dimensional guided M-mode
method. Cardiac output and stroke volume were
measured by pulsed-wave Doppler echocardiogra-
phy. At least 3 consecutive beats were measured, and
the average value was taken. The results are shown
in Figure 2. SNA was signiﬁcantly lower during BV
pacing (49:5 4:0/min) compared with RVA pac-
ing (58:8 6:9/min, p ¼ 0:016) and LV pacing
(63:3 4:3/min, p ¼ 0:002). There was no signiﬁ-
cant diﬀerence between BV pacing (49:5 4:0/min)
and re-BV pacing (49:5 2:6/min). Stroke volume
was signiﬁcantly greater during BV pacing (61:0
Figure 2
Upper panel: Recordings of raw nerve
signals, integrated sympathetic neuro-
gram, ECG and respiratory monitoring
during pacing at each site.
Lower panel: number of muscle sym-
pathetic nerve activity bursts. SNA was
signiﬁcantly lower during biventricular
pacing compared with RVA pacing and
with LV pacing. There was no signiﬁ-
cant diﬀerence between BV pacing
(49:5 4:0/min) and re-BV pacing.
MSNA, muscle sympathetic neural ac-
tivity; BV, biventricular; RV, right
ventricular; LV, left ventricular; NIBP,
non-invasive blood pressure; SV, stroke
volume.
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1:1ml) compared with RVA pacing (51:2 1:3ml,
p ¼ 0:0008) and LV pacing (48:9 0:8ml, p ¼
0:0004).
Discussion
The main ﬁndings in this case were that (1) BV
pacing improved hemodynamics and decreased
sympathetic activity compared with RVA or LV
pacing, (2) the change in sympathetic activity
occurred within a few minutes, and (3) LV pacing
alone did not improve hemodynamics or decrease
sympathetic activity. Sympathetic nerve activity of
humans can only be directly observed by means of
the microneurogram.9,10) Increased sympathetic ac-
tivity has been shown to be a negative prognostic
factor in patients with congestive heart failure.11–13)
If this ﬁnding were conﬁrmed in many patients with
chronic atrial ﬁbrillation with severe congestive
heart failure, biventricular pacing could be used to
improve the prognosis of those patients. Hamdan et
al. showed a decrease in SNA in patients with
congestive heart failure in sinus rhythm during
temporary pacing.8) Our case was compatible with
their report. However, they reported that LV pacing
alone also reduced sympathetic nerve activity. LV
pacing was the worst mode in our case. Our case had
chronic atrial ﬁbrillation with bradycardia and no
intrinsic beats during 80 per minute pacing. There-
fore, LV pacing alone could not improve dyssyn-
chrony of the LV wall. This study was performed 30
days after the initiation of biventricular therapy. In
our study, there was no signiﬁcant diﬀerence
between BV pacing and re-BV pacing. This fact
conﬁrms the reproducibility of sympathetic neural
responses in this study, and the change in sympa-
thetic activity and hemodynamics occurred within a
few minutes in the chronic phase of biventricular
pacing. The decrease in sympathetic activity may
result in an improved survival rate. This case report
only assessed short term change of sympathetic
activity so further investigations are needed. How-
ever, our ﬁndings in this case support the use of
biventricular therapy in patients with chronic atrial
ﬁbrillation and severe congestive heart failure.
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